By Dennis Ford, Founder & CEO, Life Science Nation; Creator of LSN Healthtech Partnering Week
Life Science Nation (LSN) Healthtech Partnering Week 2021 launches January 11-15, 2021 with a partnering trifecta – three back-to-back digital partnering conferences: Redefining Early Stage Investments (RESI), 4D Meets AI, and Longevity, Health & Innovation (LHI). LSN’s RESI conference series has been very successful co-located with the J.P. Morgan Annual Healthcare Conference and will continue to grow with its two newest digital partnering conferences as a quarterly, global healthcare event trifecta hosting thousands of attendees each week.
Balancing out the trifecta is LSN‘ s newest digital partnering conference, Longevity, Health & Innovation, co-organized with Mary Furlong & Associates, the preeminent leader in the longevity education market. LSN has seen tremendous growth in early-stage partnerships throughout life science and healthcare and looks forward to expanding through the week-long partnering event. The need to connect buyers and sellers is greater than ever, and this partnership will build on prior success to facilitate these conversations in the longevity market.
Learn more about the three events:
Redefining Early-Stage Investments (RESI) – January 11-13, 2021
The Redefining Early Stage Investments (RESI) conference series was created by Life Science Nation (LSN) to bring together startups with early-stage investors and strategic channel partners to maximize the capability of these companies, from seed to series B, to find partners who are a fit for their technology and stage of development. RESI is cross-border and cross-domain, connecting start-ups with ten categories of global investors across the silos of drugs, devices, diagnostics, and digital health. RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding.
4D Meets AI (4D) – January 14-15, 2021
Artificial intelligence (AI) is rapidly reshaping the healthcare landscape, and redefining what is possible in life science. The business of AI is broken down into two groups: the buyers and the sellers. 4D Meets AI is a partnering conference that connects the investors and strategic partners and matches them to companies developing and commercializing AI technology in drugs, devices, diagnostics, and digital health (the 4 Ds) to revolutionize healthcare. In addition to pitch sessions and one-on-one meetings hosted by our premier partnering platform, 4D Meets AI features investor and application panels to expand your knowledge of the industry and learn the latest trends and developments. This two-day digital conference provides the opportunity to meet strategic partners, learn from the experts, and build relationships to advance the future of healthcare.
Longevity, Health & Innovation (LHI), Co-Organized with Mary Furlong & Associates – January 14-15, 2021
The aging boomer population contributed $8.3 trillion in economic activity to the 2018 US economy, and that number is projected to triple by 2050. The need for advancements in drugs, devices, diagnostics, and digital health for the treatment of age-related conditions is crucial. Longevity, Health & Innovation (LHI) is a new partnering conference focused on conditions related to aging, market challenges, and solutions via early-stage companies and their promising tech and products. LHI brings fundraising startups together with investors in longevity innovation to make deals in order that today’s seniors live longer, healthier lives.
Annette Bakker, the Children’s Tumor Foundation’s President, holds a PhD in cell biology from the University of Antwerp. Her past experience includes serving as Oncology Group Leader at Janssen Pharmaceutica, and postdoctoral fellowships at Yale University and La Salpetriere, Paris. Before joining the Children’s Tumor Foundation, Dr. Bakker served as head of the Oncology R&D department for a biotech company in Siena, Tuscany. While there, she designed and created a neuro-oncology department from the ground up, and managed large oncology research initiatives both nationally (Italian networks) and internationally (European and Asian networks). Dr. Bakker’s research has been internationally recognized by more than 30 peer-reviewed papers, patents, and awards, and she has extensive experience liaising and negotiating with biotechnology and pharmaceutical companies. In her role at the Children’s Tumor Foundation, Annette and her team will continue to build a strong NF community, design and execute innovative business models to accelerate the path from basic discovery to clinical benefit for NF patients, develop partnerships with pharmaceutical and biotech industries, and attract new scientists and funders to the NF field. Annette is originally from Belgium, and speaks four languages (English, French, Dutch, and Italian). She lives happily in Westchester, NY with her family.
Senior executive with expertise in non-profit management, strategic planning, fundraising, sponsorship, events, volunteer engagement, major gifts and communications. Results-oriented leader with established track record of building collaborative relationships with Board members, volunteer leaders, donors and corporate partners resulting in campaign revenue milestones. Experienced manager with the ability to coach and develop staff in different roles across an organization.
Next Phase Newsletter 